HER2-Positive Primary Breast Cancer
1 competing product in clinical development for HER2-Positive Primary Breast Cancer.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| DS-8201a + T-DM1 | Daiichi Sankyo | Phase 3 | Active | 44 |
1 competing product in clinical development for HER2-Positive Primary Breast Cancer.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| DS-8201a + T-DM1 | Daiichi Sankyo | Phase 3 | Active | 44 |